Navigation Links
Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab)
Date:7/17/2009

THOUSAND OAKS, Calif., July 17 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved revisions to the U.S. prescribing information for the epidermal growth factor receptor (EGFr) class of antibodies, including Vectibix((R)) (panitumumab). This decision follows the FDA's December 2008 Oncologics Drugs Advisory Committee (ODAC) meeting where the clinical utility of the KRAS gene as a predictive biomarker in patients with metastatic colorectal cancer (mCRC) treated with anti-EGFr antibody was discussed.

"We are pleased that the FDA has recognized the clinical importance of KRAS as a predictive biomarker for anti-EGFr antibody therapy," said Sean Harper, M.D., chief medical officer and head of Global Development at Amgen.

The INDICATION AND USAGE section of the prescribing information has been updated to include that retrospective subset analyses of metastatic colorectal cancer trials have not shown a treatment benefit for Vectibix in patients whose tumors had KRAS mutations in codon 12 or 13. Use of Vectibix is not recommended for the treatment of colorectal cancer with these mutations.

The CLINICAL STUDIES section of the prescribing information has been updated to reflect results from retrospective analyses across seven randomized clinical trials with agents in this class. This includes the first Phase 3 analysis that showed mCRC patients with mutated KRAS tumors do not respond to monotherapy with an EGFr-inhibiting antibody (the Vectibix "408" trial).

"With this label update, physicians can now eliminate anti-EGFr antibodies as a treatment option for patients with mutated KRAS tumors and redirect those patients to alternative therapi
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Amgen Appoints Rebecca M. Henderson to the Companys Board of Directors
2. 34 Outstanding Teachers and Schools Receive $10,000 Amgen Award for Science Teaching Excellence
3. AUDIO from Medialink and Amgen: Experts Agree Infection in Cancer Patients Impacts Treatment Success
4. Amgen to Present at the Goldman Sachs Global Healthcare Conference
5. Loyola fellow receives Amgen grant to study treatments for older leukemia patients
6. Amgens Denosumab and Eli Lillys Forteo/Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018
7. Amgen Highlights Data to Be Presented at ASCO
8. Amgen to Present at the Deutsche Bank 34th Annual Healthcare Conference
9. Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
10. Amgens First Quarter 2009 Adjusted Earnings Per Share Decreased 4 Percent to $1.08
11. Amgen Announces Webcast of 2009 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Ohio (PRWEB) September 30, 2014 Life ... which provides CHL access to Life Length’s proprietary Telomere ... advanced and comprehensive telomere test on the market today, ... reports the percentage of short telomeres, providing the most ... Vice Chairman of the Department of Cell Biology at ...
(Date:9/30/2014)... Market Research Report on Global and ... in-depth market survey on Global and Chinese Cialis ... of Cialis including its classification, application and manufacturing ... top manufacturers of Cialis listing their product specification, ... The report further analyzes quantitatively 2009-2014 global and ...
(Date:9/30/2014)... 30, 2014 Catalent Pharma Solutions ... delivery technologies and development solutions for drugs, biologics ... agenda for the 25th Annual CPhI Worldwide Exhibition ... 6th to 9th. , Catalent is showcasing a ... during the show, including its facilities in China ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 ADOAMNI, ... first “crowdfunding” campaign through GoFundMe. The campaign, which surpassed ... for a portion of the funds necessary to convert ... for the Stockton Unified School District (SUSD). The campaign ... provide a portion of the funds necessary for the ...
(Date:9/30/2014)... The American Parkinson Disease ... supporting seven Research grants to junior investigators pursuing ... support post-doctoral scientists whose research training holds promise ... and treatment of Parkinson’s disease, and eight Centers ... medical centers across the country intended to strengthen ...
Breaking Medicine News(10 mins):Health News:Life Length® Announces New Partnership with Cleveland HeartLab® to Offer Telomere Technology in North America 2Health News:Life Length® Announces New Partnership with Cleveland HeartLab® to Offer Telomere Technology in North America 3Health News:Cialis Industry (CAS 171596-29-5) Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Cialis Industry (CAS 171596-29-5) Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Cialis Industry (CAS 171596-29-5) Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 2Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 3Health News:ADOMANI Raises More Than 100,000 Dollars Through GoFundMe to Convert a School Bus 2Health News:ADOMANI Raises More Than 100,000 Dollars Through GoFundMe to Convert a School Bus 3Health News:The American Parkinson Disease Association Awards $1.1 million in Research Grants and Continues to Lead the Way to Ease the Burden – Find the Cure for Parkinson’s Disease 2Health News:The American Parkinson Disease Association Awards $1.1 million in Research Grants and Continues to Lead the Way to Ease the Burden – Find the Cure for Parkinson’s Disease 3Health News:The American Parkinson Disease Association Awards $1.1 million in Research Grants and Continues to Lead the Way to Ease the Burden – Find the Cure for Parkinson’s Disease 4
... the opposing team,s offensive drive to the end zone, ... events to initiate, or block, different actions or functions. ... Center recently discovered a potential molecular playbook for blocking ... a well-known precursor of heart failure. Researchers uncovered a ...
... and GLG Pharma, LLC announced today that they have ... LLC has acquired the exclusive worldwide rights to a ... Researchers at Moffitt discovered several classes of STAT3 ... drugs. "Persistently activated STAT3 is a major ...
... concerted effort to boost research on women,s health over the ... reduced deaths among women due to cardiovascular disease, breast cancer, ... of Medicine. The effort has yielded less but still ... osteoporosis on women, added the committee that wrote the report. ...
... 2010) -- One-year data from the PARTNER clinical ... Journal of Medicine , demonstrate that transcatheter aortic-valve ... lower rates of death among patients who cannot ... be presented tomorrow as a Late Breaking Trial ...
... HealthDay Reporter , WEDNESDAY, Sept. 22 (HealthDay News) ... adults to asthma. Some of the genes tell the ... damaged. Others may control healing of the airways after they ... are different genes for children than for adults," said study ...
... cancer often suffer from functional limitations that affect motion, ... competing-cause survival but not breast cancer survival, according to ... Journal of the National Cancer Institute. ... affect motion, strength, and dexterity are at the same ...
Cached Medicine News:Health News:Molecular 'playbook' for halting heart failure risk factor uncovered 2Health News:Increased attention to women's health research has yielded gains on some important conditions, but progress lags on others 2Health News:Increased attention to women's health research has yielded gains on some important conditions, but progress lags on others 3Health News:Clinical trial establishes catheter-based aortic valve replacement as new standard of care 2Health News:Clinical trial establishes catheter-based aortic valve replacement as new standard of care 3Health News:Clinical trial establishes catheter-based aortic valve replacement as new standard of care 4Health News:European Researchers Find Genes Tied to Asthma 2Health News:Physical limitations of breast cancer survivors 2
(Date:9/30/2014)... 2014 The report based on ... Share, Growth and Forecast, 2007 - 2017," elaborated by ... 20.8 billion in 2012 and is further expected to ... CAGR of 7.3% from 2012 to 2017. ... purposes, especially to prevent chronic diseases that may occur ...
(Date:9/30/2014)... , September 30, 2014 ... the CSF (Cerebrospinal Fluid) backflow of the Eldor spinal ... of the single hole pencil point spinal needles of ... Braun. Spinal anesthesia is an excellent type ... Orthopedics, Urology, General Anesthesia, etc. It is ...
(Date:9/30/2014)...   Acutus Medical, Inc. (ACM), a ... Cardiac Chamber Imaging and Dipole Density Mapping system to ... complex cardiac arrhythmias, including atrial fibrillation, announced it has ... imaging/mapping system as well as bring to market a ... to complete work on the AcQMap TM High ...
Breaking Medicine Technology:Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 4Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 2Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 3
... When it comes to breast cancer, a physician,s ability ... of treatment depends on the quality of information revealed through ... the most advanced technology in breast cancer detection with positron ... PEM scanners in the Chicagoland area. Essentially, PEM ...
... BETHLEHEM, Pa., Nov. 1, 2011 Saladax Biomedical, Inc., ... assays to achieve the promise of personalized medicine for ... M.D., has accepted to chair the company,s scientific advisory ... as chief of the Division of Hematology/Oncology in the ...
Cached Medicine Technology:Palos Offers New Technology in the Fight Against Breast Cancer 2Saladax Biomedical, Inc. Names Edward Chu, M.D., Chair of the Company's Scientific Advisory Board 2Saladax Biomedical, Inc. Names Edward Chu, M.D., Chair of the Company's Scientific Advisory Board 3
The VPAP III ST is a complete system solution for SDB, providing comfortable and effective bilevel treatment with additional treatment modes. The VPAP III ST is an effective business solution for cli...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
... The BiPAP Pro with Bi-Flex bi-level ... time that the BiPAP Pro takes to ... includes Digital Auto-Trak Sensitivity™ which automatically triggers ... expiratory pressures based on the patients breathing ...
... Electrophoresis System (PGGE) is designed to ... density lipoproteins (LDL) and high density ... using nondenaturing pore gradient gel electrophoresis. ... short DNA sequencing runs. Temperature control ...
Medicine Products: